<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01632683</url>
  </required_header>
  <id_info>
    <org_study_id>62199040</org_study_id>
    <nct_id>NCT01632683</nct_id>
  </id_info>
  <brief_title>STorz Against Glidescope Effectiveness</brief_title>
  <acronym>STAGE</acronym>
  <official_title>Comparative Effectiveness of the C-MAC D-blade to Glidescope Videolaryngoscope in the Predicted Difficult Airway</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates success rates of tracheal intubation (passing a breathing tube)for
      patients who may be more challenging to intubate while utilizing one of two devices that
      facilitate placement of the tube with video technology.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intubation Success Rate</measure>
    <time_frame>1 week</time_frame>
    <description>Success rate is defined as a single blade insertion with successful tracheal tube placement confirmed by return of end-tidal carbon dioxide</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intubation Time</measure>
    <time_frame>1 week</time_frame>
    <description>Intubation time is defined as the time from blade insertion to first return of end-tidal carbon dioxide</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Graded Score of Laryngeal View Achieved</measure>
    <time_frame>1 week</time_frame>
    <description>Laryngeal view is defined by the modified Cormack and Lehane scale (1-4) and is assessed by the clinician and the study team. Grade 1 is considered to be a good view while grade 4 is considered to be a poor view.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Particpants Requiring Adjuncts to Assist Intubation</measure>
    <time_frame>1 week</time_frame>
    <description>The need for use of a gum-elastic bougie or external laryngeal manipulation to facilitate tube placement will be measured by the study team.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Observed Complications</measure>
    <time_frame>1 week</time_frame>
    <description>Patients will be examined for evidence of mucosal or dental injury upon intervention. Patients will be asked if they have a sore throat in the recovery room, and their medical record will be reviewed to determine if any other airway related complications were observed by the clinical team including the need for reintubation or steroid administration to reduce swelling.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1100</enrollment>
  <condition>Difficult Airway</condition>
  <arm_group>
    <arm_group_label>C-MAC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Providers will utilize the C-MAC video laryngoscope equipped with a D-blade to facilitate intubation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glidescope</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Providers will utilize the Glidescope video laryngoscope equipped with the #4 blade to facilitate intubation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>C-MAC</intervention_name>
    <description>C-MAC arm</description>
    <arm_group_label>C-MAC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Glidescope</intervention_name>
    <description>Glidescope arm</description>
    <arm_group_label>Glidescope</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult 18 years of age

          -  Mallampati classification scale score of 3 or 4

          -  Neck circumference greater than 40cm for males, 38 cm for females

          -  mouth opening less than 3cm, but greater than 2cm

        Exclusion Criteria:

          -  children

          -  prisoners

          -  history of easy intubation (success on first attempt with direct laryngoscopy)

          -  known unstable cervical spine injury

          -  emergency surgery

          -  nasal intubation route

          -  planned awake technique
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Aziz MF, Dillman D, Fu R, Brambrink AM. Comparative effectiveness of the C-MAC video laryngoscope versus direct laryngoscopy in the setting of the predicted difficult airway. Anesthesiology. 2012 Mar;116(3):629-36. doi: 10.1097/ALN.0b013e318246ea34.</citation>
    <PMID>22261795</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2012</study_first_submitted>
  <study_first_submitted_qc>June 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2012</study_first_posted>
  <results_first_submitted>September 30, 2014</results_first_submitted>
  <results_first_submitted_qc>October 6, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 7, 2014</results_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Michael Aziz</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>difficult airway</keyword>
  <keyword>video laryngoscopy</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>C-MAC</title>
          <description>Providers will utilize the C-MAC video laryngoscope equipped with a D-blade to facilitate intubation
C-MAC: C-MAC arm</description>
        </group>
        <group group_id="P2">
          <title>Glidescope</title>
          <description>Providers will utilize the Glidescope video laryngoscope equipped with the #4 blade to facilitate intubation
Glidescope: Glidescope arm</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="548"/>
                <participants group_id="P2" count="552"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="548"/>
                <participants group_id="P2" count="552"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>C-MAC</title>
          <description>Providers will utilize the C-MAC video laryngoscope equipped with a D-blade to facilitate intubation
C-MAC: C-MAC arm</description>
        </group>
        <group group_id="B2">
          <title>Glidescope</title>
          <description>Providers will utilize the Glidescope video laryngoscope equipped with the #4 blade to facilitate intubation
Glidescope: Glidescope arm</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="548"/>
            <count group_id="B2" value="552"/>
            <count group_id="B3" value="1100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53" spread="13.7"/>
                    <measurement group_id="B2" value="54.4" spread="14.1"/>
                    <measurement group_id="B3" value="53.7" spread="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="292"/>
                    <measurement group_id="B2" value="267"/>
                    <measurement group_id="B3" value="559"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="256"/>
                    <measurement group_id="B2" value="285"/>
                    <measurement group_id="B3" value="541"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Intubation Success Rate</title>
        <description>Success rate is defined as a single blade insertion with successful tracheal tube placement confirmed by return of end-tidal carbon dioxide</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>C-MAC</title>
            <description>Providers will utilize the C-MAC video laryngoscope equipped with a D-blade to facilitate intubation
C-MAC: C-MAC arm</description>
          </group>
          <group group_id="O2">
            <title>Glidescope</title>
            <description>Providers will utilize the Glidescope video laryngoscope equipped with the #4 blade to facilitate intubation
Glidescope: Glidescope arm</description>
          </group>
        </group_list>
        <measure>
          <title>Intubation Success Rate</title>
          <description>Success rate is defined as a single blade insertion with successful tracheal tube placement confirmed by return of end-tidal carbon dioxide</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="548"/>
                <count group_id="O2" value="552"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="512"/>
                    <measurement group_id="O2" value="531"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intubation Time</title>
        <description>Intubation time is defined as the time from blade insertion to first return of end-tidal carbon dioxide</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>C-MAC</title>
            <description>Providers will utilize the C-MAC video laryngoscope equipped with a D-blade to facilitate intubation
C-MAC: C-MAC arm</description>
          </group>
          <group group_id="O2">
            <title>Glidescope</title>
            <description>Providers will utilize the Glidescope video laryngoscope equipped with the #4 blade to facilitate intubation
Glidescope: Glidescope arm</description>
          </group>
        </group_list>
        <measure>
          <title>Intubation Time</title>
          <description>Intubation time is defined as the time from blade insertion to first return of end-tidal carbon dioxide</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="548"/>
                <count group_id="O2" value="552"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47" lower_limit="39" upper_limit="60"/>
                    <measurement group_id="O2" value="47" lower_limit="38" upper_limit="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Graded Score of Laryngeal View Achieved</title>
        <description>Laryngeal view is defined by the modified Cormack and Lehane scale (1-4) and is assessed by the clinician and the study team. Grade 1 is considered to be a good view while grade 4 is considered to be a poor view.</description>
        <time_frame>1 week</time_frame>
        <population>Cormack-Lehane grade</population>
        <group_list>
          <group group_id="O1">
            <title>C-MAC</title>
            <description>Providers will utilize the C-MAC video laryngoscope equipped with a D-blade to facilitate intubation
C-MAC: C-MAC arm</description>
          </group>
          <group group_id="O2">
            <title>Glidescope</title>
            <description>Providers will utilize the Glidescope video laryngoscope equipped with the #4 blade to facilitate intubation
Glidescope: Glidescope arm</description>
          </group>
        </group_list>
        <measure>
          <title>Graded Score of Laryngeal View Achieved</title>
          <description>Laryngeal view is defined by the modified Cormack and Lehane scale (1-4) and is assessed by the clinician and the study team. Grade 1 is considered to be a good view while grade 4 is considered to be a poor view.</description>
          <population>Cormack-Lehane grade</population>
          <units>participants</units>
          <param>Number</param>
          <units_analyzed>grade</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="541"/>
                <count group_id="O2" value="557"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>grade</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="482"/>
                    <measurement group_id="O2" value="398"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Particpants Requiring Adjuncts to Assist Intubation</title>
        <description>The need for use of a gum-elastic bougie or external laryngeal manipulation to facilitate tube placement will be measured by the study team.</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>C-MAC</title>
            <description>Providers will utilize the C-MAC video laryngoscope equipped with a D-blade to facilitate intubation
C-MAC: C-MAC arm</description>
          </group>
          <group group_id="O2">
            <title>Glidescope</title>
            <description>Providers will utilize the Glidescope video laryngoscope equipped with the #4 blade to facilitate intubation
Glidescope: Glidescope arm</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Particpants Requiring Adjuncts to Assist Intubation</title>
          <description>The need for use of a gum-elastic bougie or external laryngeal manipulation to facilitate tube placement will be measured by the study team.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="548"/>
                <count group_id="O2" value="552"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="117"/>
                    <measurement group_id="O2" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Observed Complications</title>
        <description>Patients will be examined for evidence of mucosal or dental injury upon intervention. Patients will be asked if they have a sore throat in the recovery room, and their medical record will be reviewed to determine if any other airway related complications were observed by the clinical team including the need for reintubation or steroid administration to reduce swelling.</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>C-MAC</title>
            <description>Providers will utilize the C-MAC video laryngoscope equipped with a D-blade to facilitate intubation
C-MAC: C-MAC arm</description>
          </group>
          <group group_id="O2">
            <title>Glidescope</title>
            <description>Providers will utilize the Glidescope video laryngoscope equipped with the #4 blade to facilitate intubation
Glidescope: Glidescope arm</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Observed Complications</title>
          <description>Patients will be examined for evidence of mucosal or dental injury upon intervention. Patients will be asked if they have a sore throat in the recovery room, and their medical record will be reviewed to determine if any other airway related complications were observed by the clinical team including the need for reintubation or steroid administration to reduce swelling.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="548"/>
                <count group_id="O2" value="552"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97"/>
                    <measurement group_id="O2" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>C-MAC</title>
          <description>Providers will utilize the C-MAC video laryngoscope equipped with a D-blade to facilitate intubation
C-MAC: C-MAC arm</description>
        </group>
        <group group_id="E2">
          <title>Glidescope</title>
          <description>Providers will utilize the Glidescope video laryngoscope equipped with the #4 blade to facilitate intubation
Glidescope: Glidescope arm</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="548"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="552"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="548"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="552"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>pharyngeal injury</sub_title>
                <description>pharyngeal injury</description>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="548"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="552"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michael Aziz, MD</name_or_title>
      <organization>Oregon Health &amp; Science University</organization>
      <phone>503-494-5581</phone>
      <email>azizm@ohsu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

